Related Experiment Video
Updated: Aug 30, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
Thrombosis and cardiovascular risk in the elderly
1Department of Pathology, University of Vermont, Burlington.
Insights
Understanding thrombosis risk factors in the elderly is crucial for cardiovascular disease. Research is ongoing to clarify the roles of fibrinogen, Factor VII, and plasminogen activator inhibitor-1 in older adults.
Area of Science:
- Cardiovascular Science
- Thrombosis Research
- Geriatric Medicine
Background:
- Thrombosis plays a key role in cardiovascular disease (CVD) pathophysiology, precipitating clinical events and contributing to atherosclerosis.
- Current understanding of thrombotic risk factors, particularly in the elderly population, remains limited.
- While fibrinogen is an established risk factor in middle-aged adults, its role in older individuals is debated, and data on Factor VII and plasminogen activator inhibitor-1 in the elderly are lacking.
Purpose of the Study:
- To highlight the current gaps in knowledge regarding thrombotic risk factors in the elderly.
- To emphasize the need for further research into specific thrombotic factors like fibrinogen, Factor VII, and plasminogen activator inhibitor-1 in older populations.
- To explore the complex interactions between thrombotic risk factors and other CVD risk factors in the elderly.
Main Methods:
- Review of current literature on thrombosis and cardiovascular disease pathophysiology.
- Identification of established and potential thrombotic risk factors.
- Analysis of existing data and identification of research gaps, especially concerning the elderly.
Main Results:
- Fibrinogen is a recognized independent risk factor in middle-aged individuals, but data for older adults are conflicting.
- Factor VII and plasminogen activator inhibitor-1 show promise as risk factors in middle-aged individuals, with limited data in the elderly.
- Complex associations exist between thrombotic factors and other CVD risk factors (lipids, glucose intolerance), complicating the establishment of independence, especially in older individuals.
Conclusions:
- Further research is urgently needed to elucidate the role and independence of thrombotic risk factors in the elderly.
- Understanding these factors and their interactions is critical for developing effective CVD prevention strategies in aging populations.
- Ongoing studies are expected to provide significant insights into thrombotic risk in the elderly in the near future.
Abstract:
Current concepts of cardiovascular disease pathophysiology include a prominent role for thrombosis as a key factor. Thrombosis is not only the usual precipitant to a clinical event, but it may also be involved in atherosclerotic plaque development throughout most of the adult years. However, our understanding of thrombotic risk factors, especially in the elderly, is poor and research has just begun in this area. Fibrinogen has been clearly established as an independent risk factor in the middle aged, but there are conflicting data concerning older persons. Factor VII and plasminogen activator inhibitor-1 look promising as risk factors in the middle aged, but there are no data currently available concerning the status of these factors in the elderly. Many associations exist between the thrombotic risk factors and other cardiovascular risk factors such as plasma lipids and glucose intolerance, making the establishment of independence difficult, and little is known about how these different factors may interact in older individuals. Ongoing studies should provide many answers in the near future.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Drug Dosing: Geriatric Patients
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

